In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Stressgen and Roche announce global collaboration
StressGen Initiates Phase II clinical trial of HspE7
Stressgen granted European patent
Antigenics receives heat shock protein patent
Antigenics announces issuance of US patent
Pfizer to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform
Stressgen receives Roche milestones totaling US$4.5 million
Protein Design to buy back Zenapax rights from Roche for $80 million